CN101849992A - Medicament for treating inferior turbinate hypertrophy and method for preparing same - Google Patents

Medicament for treating inferior turbinate hypertrophy and method for preparing same Download PDF

Info

Publication number
CN101849992A
CN101849992A CN201010203604A CN201010203604A CN101849992A CN 101849992 A CN101849992 A CN 101849992A CN 201010203604 A CN201010203604 A CN 201010203604A CN 201010203604 A CN201010203604 A CN 201010203604A CN 101849992 A CN101849992 A CN 101849992A
Authority
CN
China
Prior art keywords
parts
inferior turbinate
medicament
treating
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201010203604A
Other languages
Chinese (zh)
Inventor
胡学岚
胡继刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201010203604A priority Critical patent/CN101849992A/en
Publication of CN101849992A publication Critical patent/CN101849992A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicament for treating inferior turbinate hypertrophy and a method for preparing the same. The medicament for treating the inferior turbinate hypertrophy consists of the following components in part by weight: 8 to 25 parts of musk, 10 to 20 parts of ephedra herb, 5 to 15 parts of biond magnolia flower, 5 to 15 parts of Chinese honeylocust fruit, 5 to 15 parts of sandwort, 10 to 25 parts of fried siberian cocklour fruit, 5 to 15 parts of euphorbia kansui, 5 to 15 parts of pangolin scales and 10 to 25 parts of Chinese angelica. The method comprises the following steps of: fully mixing the medicaments; drying and pulverizing the medicaments to be 120 meshes; boiling the powder at the temperature of between 100 and 110 DEG C and sterilizing the powder for 10 to 30 minutes; and adding moisture burn ointment in an amount which is equal to the weight of the sterilized powder into the sterilized powder and mixing the mixture uniformly. The medicament for treating the inferior turbinate hypertrophy has the advantages of economy, practicability, no use of oral medicament, no need of operation, injection or puncture, no bleeding, no pain, no damage to mucosa of nasal cavity; the patient needs not to stay in hospital and can go home immediately without affecting the work and study; and the medicament can also be used for treating chronic rhinitis, sinusitis and allergic rhinitis while treating the inferior turbinate hypertrophy.

Description

Medicine of treatment hypertrophic inferior turbinate and preparation method thereof
Technical field
The present invention relates to a kind of medicine for the treatment of hypertrophic inferior turbinate, is the Chinese patent medicine of feedstock production with the Chinese herbal medicine specifically, the invention still further relates to the preparation method of this medicine.
Background technology
Hypertrophic inferior turbinate is meant that the stimulation that concha nasalis is subjected to inflammation for a long time causes the turbinate mucosa edema, cause congestion, clinical manifestation is: headache, dizziness, persistence nasal obstruction, closed rhinolalia, snore, tinnitus, mood are fidgety, hypomnesis, decreased respiratory function, cause big cerebral anoxia.The hypertrophic inferior turbinate prevalence is up to 60%-70% in the population of China, has 8-9 hundred million people to suffer from various degree hypertrophic inferior turbinate disease approximately.
The treatment hypertrophic inferior turbinate mainly contains following three kinds of methods both at home and abroad at present, but has following insoluble problem.
1, Drug therapy: mainly be oral various rhinitis tablet, capsule for treating rhinitis, antibiotic etc, external used medicine mainly contains nasal cavity spray, rhinitis ointment etc.Employing Drug therapy hypertrophic inferior turbinate can only its symptom of respite.
2, operative treatment: the operative treatment of concha nasalis all carries out around following three aspects at present: the one, and the operation of nasal cavity sidewall, i.e. nasal septum surgery; The 2nd, nose lobe district hands art; The 3rd, the lateral wall of nasal cavity operation.Operative treatment is bigger to the hypertrophic inferior turbinate mucosa injury, and postoperative swelling, pain, hemorrhage, dry nasal cavity, easy infection, recovery time are long, also cause adhesion of nasal cavity easily, influence in various degree the function of nasal cavity.
3, naturopathy: as Therapeutic Method such as freezing, laser, microwaves.All can destroy normal nasal membrane structure when adopting physical methods such as freezing, laser, microwave to treat hypertrophic inferior turbinate, influence the physiological function of nasal cavity.
Summary of the invention
For overcoming the deficiencies in the prior art, goal of the invention of the present invention is to provide a kind of medicine for the treatment of hypertrophic inferior turbinate, another object of the present invention provides the preparation method of treatment hypertrophic inferior turbinate medicine, the present invention is based on hypertrophic inferior turbinate disease and pathogenetic understanding of complication and treatment principle, achieve with reference to modern pharmacological research, from medical treasure-house, filter out heat-clearing and toxic substances removing, activating blood circulation to dissipate blood stasis, the pure and impure medicine of letting out, by the theory of Chinese medical science prescription, skim the cream off milk, make it reach turbid yin and descend, reach on the clear sun, wash away filth, compress is pure and fresh, efficacy consolidation, the purpose of long-term stability.
For achieving the above object, medicine of the present invention is made up of the composition of following weight portion: the smelly 8-25 part of four flavors; Herba Ephedrae 10-20 part; Flos Magnoliae 5-15 part; Fructus Gleditsia 5-15 part; Sandwort 5-15 part; Fructus Xanthii (parched) 10-25 part; Radix Kansui 5-15 part; Squama Manis 5-15 part; Radix Angelicae Sinensis 10-25 part.
The composition of medicine preferred weight part of the present invention consists of: the smelly 10-15 part of four flavors; Herba Ephedrae 10-15 part; Flos Magnoliae 6-10 part; Fructus Gleditsia 5-10 part; Sandwort 6-10 part; Fructus Xanthii (parched) 15-20 part; Radix Kansui 6-10 part; Squama Manis 6-10 part; Radix Angelicae Sinensis 15-20 part.
The preparation method of medicine of the present invention is:
1. after medicine fully being mixed by component, drying and crushing to 120 order;
2. powder is carried out ripening, sterilization treatment 10-30 minute under 100-110 ℃;
3. the powder after ripening, the sterilization treatment of learning from else's experience is that 1: 1 proportioning adds the moist expose burn ointment blending evenly by weight.One of moist expose burn ointment effective ingredient cupreol has antiinflammatory, suppresses the growth and breeding effect of antibacterial, can make the pathogenic bacterium variation, reduces virulence, thereby has suppressed the growth and breeding of abel's bacillus; Another composition baicalin can be removed super oxidation base, improves the blood supply of local organization, reduces the growth of super oxidation base; The substrate of moist expose burn ointment for the growth reparation of organizing provides nutrition, is beneficial to the Regeneration and Repair of organizational structure normal condition by composition of nutritive substances such as several amino acids, fatty acid and saccharides.
The present invention is by the focus target administration, directly deep layer penetrate develop immunity to drugs, in the chemical sproof Coryzavirus cell, rapid active cell regulatory factor, high efficiency separation is subjected to the defective of Coryzavirus infringement, to mutant replace, optimize, peel off eject from external.Outside the intractable nosotoxin of removing dark plant nasal cavity, can also strengthen the nasal cavity defense function, make the quick formation of nasal cavity resist the barrier that virus is invaded together, root out the Coryzavirus ecological environment.Reparation that the toxin expelling method is powerful and regeneration capacity can promote the nasal cavity film healing, and physiological metabolism adds that normally patient self produces resistance against diseases, solve a concha nasalis inferior recurrence difficult problem from root.
Medicine of the present invention compared with prior art has following characteristics through clinical use:
1, evident in efficacy: use Drug therapy hypertrophic inferior turbinate of the present invention,, need not operate on, have an injection, puncture without oral drugs, not hemorrhage, not painful, do not damage nasal membrane; In the treatment hypertrophic inferior turbinate, also can cure chronic rhinitis, sinusitis and allergic rhinitis.The teenager cure rate can reach 100% below 20 years old; More than 20 years old to patient's cure rate of the right side of fifty 98%.
2, economical and practical: the treatment hypertrophic inferior turbinate mainly is to select operation and naturopathy method for use both at home and abroad at present, and generally in 2000-6000 unit, not only medical expense is higher for medical expense, and recurrence easily in a short time.With Drug therapy hypertrophic inferior turbinate of the present invention, every patient's medical expense is generally in 600-800 unit, and need not be in hospital, with controlling with walking, do not influence working and learning.
For showing the therapeutic effect of medicine of the present invention to hypertrophic inferior turbinate, the present invention followed up a case by regular visits to patient through the clinical observation of 100 routine systems after 24 months, only had 2 routine one's mid-40s patients that slight recurrence symptom is arranged, and the treatment effective percentage reaches 100%, and cure rate reaches 98%.
The specific embodiment
The present invention further specifies with following embodiment, but the present invention is not limited to these embodiment.
Embodiment 1
Medicine of the present invention is made (consumption is a weight portion) by following component: smelly 10 parts of four flavors; 10 parts in Herba Ephedrae; 6.5 parts of Flos Magnoliaes; 5 parts of Fructus Gleditsia; 6.5 parts of sandworts; 15 parts of Fructus Xanthii (parched)s; 7.5 parts of Radix Kansuis; 6.5 parts of Squama Maniss; 16.5 parts of Radix Angelicae Sinensis.
After said medicine fully mixed, drying and crushing to 120 order; Powder carries out ripening, sterilization treatment 10-30 minute under 100-110 ℃; Powder after ripening, sterilization treatment, it is even to be that 1: 1 proportioning adds moist expose burn ointment blending that Shantou City, Guangdong Province MEIBAO pharmaceutical Co. Ltd produces by weight.
Embodiment 2
Medicine of the present invention is made (consumption is a weight portion) by following component: smelly 18 parts of four flavors; 15 parts in Herba Ephedrae; 10.5 parts of Flos Magnoliaes; 10 parts of Fructus Gleditsia; 10.5 parts of sandworts; 18 parts of Fructus Xanthii (parched)s; 11 parts of Radix Kansuis; 10.5 parts of Squama Maniss; 18.5 parts of Radix Angelicae Sinensis.
After said medicine fully mixed, drying and crushing to 120 order; Powder carries out ripening, sterilization treatment 10-30 minute under 100-110 ℃; Powder after ripening, sterilization treatment, it is even to be that 1: 1 proportioning adds moist expose burn ointment blending that Shantou City, Guangdong Province MEIBAO pharmaceutical Co. Ltd produces by weight.
Embodiment 3
Medicine of the present invention is made (consumption is a weight portion) by following component: smelly 20 parts of four flavors; 18 parts in Herba Ephedrae; 12.5 parts of Flos Magnoliaes; 12 parts of Fructus Gleditsia; 12.5 parts of sandworts; 20 parts of Fructus Xanthii (parched)s; 13 parts of Radix Kansuis; 12.5 parts of Squama Maniss; 20.5 parts of Radix Angelicae Sinensis.
After said medicine fully mixed, drying and crushing to 120 order; Powder carries out ripening, sterilization treatment 10-30 minute under 100-110 ℃; Powder after ripening, sterilization treatment, it is even to be that 1: 1 proportioning adds moist expose burn ointment blending that Shantou City, Guangdong Province MEIBAO pharmaceutical Co. Ltd produces by weight.
The using method of medicine of the present invention: grow into the cone-shaped cotton sliver of 8-10cm with aseptic absorbent cotton system, then medicine of the present invention is spread upon on the taper cotton sliver uniformly, gently send into nasal cavity with curved tweezer, kept 24 hours, the back reuse the method treatment of three weeks once gets final product.

Claims (3)

1. medicine for the treatment of hypertrophic inferior turbinate, it is characterized in that: the composition by following weight portion is formed: the smelly 8-25 part of four flavors; Herba Ephedrae 10-20 part; Flos Magnoliae 5-15 part; Fructus Gleditsia 5-15 part; Sandwort 5-15 part; Fructus Xanthii (parched) 10-25 part; Radix Kansui 5-15 part; Squama Manis 5-15 part; Radix Angelicae Sinensis 10-25 part.
2. the medicine of treatment hypertrophic inferior turbinate according to claim 1 is characterized in that: the composition by following weight portion is formed: the smelly 10-15 part of four flavors; Herba Ephedrae 10-15 part; Flos Magnoliae 6-10 part; Fructus Gleditsia 5-10 part; Sandwort 6-10 part; Fructus Xanthii (parched) 15-20 part; Radix Kansui 6-10 part; Squama Manis 6-10 part; Radix Angelicae Sinensis 15-20 part.
3. the preparation method of the medicine of a treatment hypertrophic inferior turbinate according to claim 1, it is characterized in that: its preparation method is:
1. after medicine fully being mixed by component, drying and crushing to 120 order;
2. powder is carried out ripening, sterilization treatment 10-30 minute under 100-110 ℃;
3. the powder after ripening, the sterilization treatment of learning from else's experience is that 1: 1 proportioning adds the moist expose burn ointment blending evenly by weight.
CN201010203604A 2010-06-08 2010-06-08 Medicament for treating inferior turbinate hypertrophy and method for preparing same Pending CN101849992A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201010203604A CN101849992A (en) 2010-06-08 2010-06-08 Medicament for treating inferior turbinate hypertrophy and method for preparing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010203604A CN101849992A (en) 2010-06-08 2010-06-08 Medicament for treating inferior turbinate hypertrophy and method for preparing same

Publications (1)

Publication Number Publication Date
CN101849992A true CN101849992A (en) 2010-10-06

Family

ID=42801781

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201010203604A Pending CN101849992A (en) 2010-06-08 2010-06-08 Medicament for treating inferior turbinate hypertrophy and method for preparing same

Country Status (1)

Country Link
CN (1) CN101849992A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105561191A (en) * 2016-01-07 2016-05-11 师洪亮 Ointment for treating hypertrophy of nasal turbinate
CN106265966A (en) * 2016-10-21 2017-01-04 张有强 A kind of Chinese medicine treating sinusitis, allergic rhinitis, nasal conchae hypertrophy
CN110420298A (en) * 2019-09-04 2019-11-08 山东大学齐鲁医院 A kind of Chinese medicine composition for treating concha hypertrophy, nasal polyp

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1389244A (en) * 2002-06-17 2003-01-08 范宝增 Rhinitis-treating clove ointment
CN101474381A (en) * 2009-01-10 2009-07-08 广东顺峰药业有限公司 Medicament for treating acute and chronic rhinitis as well as preparation method thereof and nasal cavity medicine delivery device
CN101554403A (en) * 2009-05-26 2009-10-14 曹书光 Medicament for treating rhinitis and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1389244A (en) * 2002-06-17 2003-01-08 范宝增 Rhinitis-treating clove ointment
CN101474381A (en) * 2009-01-10 2009-07-08 广东顺峰药业有限公司 Medicament for treating acute and chronic rhinitis as well as preparation method thereof and nasal cavity medicine delivery device
CN101554403A (en) * 2009-05-26 2009-10-14 曹书光 Medicament for treating rhinitis and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
夏锦平: "中医外治鼻病近况", 《江苏中医》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105561191A (en) * 2016-01-07 2016-05-11 师洪亮 Ointment for treating hypertrophy of nasal turbinate
CN106265966A (en) * 2016-10-21 2017-01-04 张有强 A kind of Chinese medicine treating sinusitis, allergic rhinitis, nasal conchae hypertrophy
CN110420298A (en) * 2019-09-04 2019-11-08 山东大学齐鲁医院 A kind of Chinese medicine composition for treating concha hypertrophy, nasal polyp

Similar Documents

Publication Publication Date Title
CN102091203B (en) External traditional Chinese medicine preparation for treating refractory wound and preparation method thereof
CN106728727A (en) It is a kind of to treat ointment of sore and preparation method thereof
CN102631423A (en) Care solution for wound cleaning
CN111297961A (en) Dong medicine for promoting wound healing
CN100420460C (en) Chinese medicinal compsns. for treating burn and scald, its prepn. and usage
CN102302678A (en) Skin membrane repair drug
CN103933363A (en) Wound healing paste and preparation method thereof
CN101849992A (en) Medicament for treating inferior turbinate hypertrophy and method for preparing same
CN102716281B (en) Care solution for cleaning wounds after operation
CN106377602A (en) Dendrobium officinale composite disinfection powder, and preparation method and application method thereof
CN105560620A (en) Trauma treatment traditional Chinese medicine preparation
CN105362847A (en) Traditional Chinese medicine composition for wound care
CN101797286B (en) Chinese traditional medicine combination for alleviating wound infections and suture reaction after surgery and preparation method thereof
CN101288669A (en) Exterior-applied powder for treating pressure sore
CN106491568A (en) A kind of marine organisms spray film for treating skin injury and infection and preparation method thereof
CN106619286A (en) Beauty traditional Chinese medicinal facial mask capable of preventing and treating acnes
CN105560763A (en) Traditional Chinese medicine composition skin disinfectant
CN105497460A (en) Disinfectant for disinfecting skins
CN101317963B (en) Traditional Chinese medicine for treating exogenous injury and ulcer and preparation method thereof
CN105012348A (en) Bioactive vaginal suppository containing growth factors
CN103638205A (en) Composition for treatment of skin diseases and preparation method thereof
CN102920800A (en) Topical drug composite and application and preparation method thereof
CN102784355A (en) First-aid drug and its preparation method
CN103505567A (en) Medicament for treating periodontitis
CN103142966A (en) Medicament for wound healing

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20101006